#hereditary angioedema

1 story

#astria therapeutics #bcrx #biocryst #business #finance #nasdaq #navenibart #orladeyo #rare disease drugs

BioCryst Turns First Profit
BioCryst becomes profitable with Orladeyo and plans rare disease acquisitions.
Yahoo Finance · 1m